Invention Grant
- Patent Title: Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
-
Application No.: US16098906Application Date: 2017-05-04
-
Publication No.: US10426843B2Publication Date: 2019-10-01
- Inventor: Mark L. McLaughlin , David L. Morse
- Applicant: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. , UNIVERSITY OF SOUTH FLORIDA
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2017/030962 WO 20170504
- International Announcement: WO2017/192798 WO 20171109
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61P35/04 ; A61P35/00
Abstract:
The subject matter disclosed herein relates generally to cancer therapy and to anticancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target DOR and their use in the treatment of cancer.
Public/Granted literature
- US20190192685A1 A DELTA-OPIOID RECEPTOR TARGETED AGENT FOR MOLECULAR IMAGING AND IMMUNOTHERAPY OF CANCER Public/Granted day:2019-06-27
Information query
IPC分类:
